More specifically, according to a study by Govender et al., in patients with open tibial fractures administration of BMP-2 was accompanied by significant decrease of surgical failure risk, elimination of invasive interventions, such as bone grafting, a decrease in infections and secondary interventions rates compared to the control group [36,52]. The gene discussed is BMP2; the disease is infection.